CRYSVITA is a prescription medicine used to treat adults and children 6 months of age and older with X-linked hypophosphatemia (XLH).

 

A monoclonal antibody is a type of therapy that targets a specific protein in the body that may not be working correctly. CRYSVITA helps the body hold onto a normal amount of phosphorus by keeping FGF23 activity in check.